Advanced BioMedical Technologies (Advanced BioMedical Technologies) Change In Receivables : $-0.01 Mil (TTM As of Jul. 2021)

View and export this data going back to 2007. Start your Free Trial

What is Advanced BioMedical Technologies Change In Receivables?

Advanced BioMedical Technologies's change in receivables for the quarter that ended in Jul. 2021 was $0.01 Mil. It means Advanced BioMedical Technologies's Accounts Receivable declined by $0.01 Mil from Apr. 2021 to Jul. 2021 .

Advanced BioMedical Technologies's change in receivables for the fiscal year that ended in Oct. 2020 was $0.02 Mil. It means Advanced BioMedical Technologies's Accounts Receivable declined by $0.02 Mil from Oct. 2019 to Oct. 2020 .

Advanced BioMedical Technologies's Accounts Receivable for the quarter that ended in Jul. 2021 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Advanced BioMedical Technologies's liquidation value for the three months ended in Jul. 2021 was $-8.48 Mil.

Advanced BioMedical Technologies Change In Receivables Historical Data

The historical data trend for Advanced BioMedical Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced BioMedical Technologies Change In Receivables Chart

Advanced BioMedical Technologies Annual Data

Trend

Oct11

Oct12

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Change In Receivables

Get a 7-Day Free Trial

-0.02

0.02

Advanced BioMedical Technologies Quarterly Data
	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21
Change In Receivables	Get a 7-Day Free Trial															-	0.01	-0.03	-	0.01

Advanced BioMedical Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jul. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

Advanced BioMedical Technologies (OTCPK:ABMT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Advanced BioMedical Technologies's Days Sales Outstanding for the quarter that ended in Jul. 2021 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Advanced BioMedical Technologies's accounts receivable are only considered to be worth 75% of book value:

Advanced BioMedical Technologies's liquidation value for the quarter that ended in Jul. 2021 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.007	-	8.579	+	0.75 * 0	+	0.5 * 0.189
=	-8.48

Advanced BioMedical Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Advanced BioMedical Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced BioMedical Technologies Inc (OTCPK:ABMT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Park Avenue, Suite 1700, New York, NY, USA, 10166

Website

https://www.abtbiomedical.com

Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.

Executives

Advanced Biomedical Technologies Inc.	director, officer: CFO	200 PARK AVENUE, SUITE 1700 NEW YORK NY 10166
Lynch John Thomas Jr	other: Advisor	22 MULBERRY STREET SUITE 1B MIDDLETOWN NY 10940
Chi Ming Yu	director, 10 percent owner, officer: PRESIDENT	36 CLAREMONT TERRACE WAYNE NJ 07470
Andriy Protskiv	director, 10 percent owner, officer: President, CEO, CFO	706-15038 101 AVENUE SURREY A1 V3R 0N2

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Headlines

From GuruFocus

Advanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws

By Marketwired Marketwired • 04-19-2018

Advanced Biomedical Technologies Inc. Launches Sales Campaign

By Marketwired Marketwired • 11-06-2019